Oncology News & Articles

1 Disseminated tumor cells in pancreatic cancer--an independent prognosticator of disease progression and survival International Journal of Cancer, May 18, 2012

2 The Implications of Positive Peritoneal Lavage Cytology in Potentially Resectable Pancreatic Cancer World Journal of Surgery, May 18, 2012

3 Diagnostic Strategy for Differentiating Autoimmune Pancreatitis From Pancreatic Cancer: Is an Endoscopic Retrograde Pancreatography Essential Pancreas, May 18, 2012    Clinical Article

4 Value of Cytodiagnosis Using Endoscopic Nasopancreatic Drainage for Early Diagnosis of Pancreatic Cancer: Establishing a New Method for the Early Detection of Pancreatic Carcinoma In Situ Pancreas, May 18, 2012    Clinical Article

5 Neural invasion induces cachexia via astrocytic activation of neural route in pancreatic cancer International Journal of Cancer, May 18, 2012

6 Clinicodemographic aspect of resectable pancreatic cancer and prognostic factors for resectable cancer World Journal of Surgical Oncology, May 18, 2012

7 Hypermethylation of HIC1 Promoter and Aberrant Expression of HIC1/SIRT1 Might Contribute to the Carcinogenesis of Pancreatic Cancer Annals of Surgical Oncology, May 18, 2012

8 TNM Staging of Neoplasms of the Endocrine Pancreas: Results From a Large International Cohort Study Journal of the National Cancer Institute, May 2, 2012

9 Long-term outcomes of neoadjuvant chemotherapy before chemoradiation for locally advanced pancreatic cancer Cancer, May 2, 2012    Clinical Article

10 Stool DNA testing for the detection of pancreatic cancer Cancer, May 2, 2012    Clinical Article

11 Conditional survival in patients with pancreatic ductal adenocarcinoma resected with curative intent Cancer, May 2, 2012

12 Serum autoantibodies to pancreatic cancer antigens as biomarkers of pancreatic cancer in a San Francisco Bay Area case-control study Cancer, May 2, 2012    Clinical Article

13 Treatment of pancreatic cancer using an oncolytic virus harboring the lipocalin-2 gene Cancer, May 2, 2012

14 The functional cytotoxic T lymphocyte-associated Protein 4 49G-to-A genetic variant and risk of pancreatic cancer Cancer, May 2, 2012

15 Histologic grading the extent of residual carcinoma following neoadjuvant chemoradiation in pancreatic ductal adenocarcinoma Cancer, May 2, 2012

16 The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal Full Text Journal of Gastrointestinal Oncology, May 2, 2012    Clinical Article

17 Combination of plasma microRNAs with serum CA19-9 for early detection of pancreatic cancer International Journal of Cancer, May 2, 2012    Clinical Article

18 ABO blood group, hepatitis B viral infection and risk of pancreatic cancer International Journal of Cancer, May 2, 2012    Clinical Article

19 Dietary fructose, carbohydrates, glycemic indices and pancreatic cancer risk: a systematic review and meta-analysis of cohort studies Annals of Oncology, May 2, 2012    Evidence Based Medicine    Clinical Article

20 Plasma cotinine levels and pancreatic cancer in the EPIC cohort study International Journal of Cancer, May 2, 2012    Clinical Article

21 Effects of capsid-modified oncolytic adenoviruses and their combinations with gemcitabine or silica gel on pancreatic cancer International Journal of Cancer, May 2, 2012    Clinical Article

22 Pancreatoduodenectomy Following Neoadjuvant Chemoradiation Therapy in Uncinate Process Pancreatic Cancer Pancreas, May 2, 2012

23 A single-nucleotide polymorphism in tumor suppressor gene SEL1L as a predictive and prognostic marker for pancreatic ductal adenocarcinoma in caucasians Molecular Carcinogenesis, May 2, 2012

24 Presence of Somatic Mutations in Most Early-Stage Pancreatic Intraepithelial Neoplasia Gastroenterology, May 2, 2012

25 Comparison of radiation treatment delivery for pancreatic cancer: Linac intensity-modulated radiotherapy versus helical tomotherapy Journal of Medical Imaging and Radiation Oncology (JMIRO), May 2, 2012

26 Genetic variants in carcinogen-metabolizing enzymes, cigarette smoking and pancreatic cancer risk Carcinogenesis, May 2, 2012    Clinical Article

27 Long-Term Follow-Up of Nutritional Status, Pancreatic Function, and Morphological Changes of the Pancreatic Remnant After Pancreatic Tumor Resection in Children Pancreas, May 2, 2012

28 DJ-1, a novel biomarker and a selected target gene for overcoming chemoresistance in pancreatic cancer Journal of Cancer Research & Clinical Oncology, May 2, 2012    Clinical Article

29 Efficacy and safety of self-expandable metal stents for biliary decompression in patients receiving neoadjuvant therapy for pancreatic cancer: a prospective study Gastrointestinal Endoscopy, May 2, 2012    Clinical Article

30 Serum HSP70: A Novel Biomarker for Early Detection of Pancreatic Cancer Pancreas, May 2, 2012

31 Overexpression of FOXM1 Is Associated With Poor Prognosis and Clinicopathologic Stage of Pancreatic Ductal Adenocarcinoma Pancreas, May 2, 2012

32 SMAD4 Genetic Alterations Predict a Worse Prognosis in Patients With Pancreatic Ductal Adenocarcinoma Pancreas, May 2, 2012

33 Serum CA19-9 is a Significant Predictor among Preoperative Parameters for Early Recurrence after Resection of Pancreatic Adenocarcinoma Journal of Gastrointestinal Surgery, April 16, 2012

34 Dietary intake of iron, heme-iron and magnesium and pancreatic cancer risk in the European prospective investigation into cancer and nutrition (EPIC) cohort International Journal of Cancer, April 16, 2012    Clinical Article

35 Distal Pancreatectomy with En Bloc Celiac Axis Resection for Locally Advanced Pancreatic Adenocarcinoma Following Neoadjuvant Therapy Journal of Gastrointestinal Surgery, April 16, 2012

36 Number of Lymph Nodes Evaluated: Prognostic Value in Pancreatic Adenocarcinoma Journal of Gastrointestinal Surgery, April 16, 2012

37 Increased CDC20 expression is associated with pancreatic ductal adenocarcinoma differentiation and progression Journal of Hematology & Oncology, April 16, 2012

38 Syndecan-2 promotes perineural invasion and cooperates with K-ras to induce an invasive pancreatic cancer cell phenotype Full Text Molecular Cancer, April 16, 2012

39 Effect of a combination of S-1 and gemcitabine on cell cycle regulation in pancreatic cancer cell lines Anti-Cancer Drugs, April 16, 2012    Clinical Article

40 Quality of Clinical Trials in Gastro-Entero-Pancreatic Neuroendocrine Tumours Neuroendocrinology, April 16, 2012

41 Utility of Nuclear Magnetic Resonance Spectroscopy for Pancreatic Cancer Studies Pancreas, April 16, 2012

42 An International Multicenter Randomized Controlled Trial of G17DT in Patients With Pancreatic Cancer Pancreas, March 31, 2012

43 Impact of comorbidities and surgery on health related transitions in pancreatic cancer admissions: A multi state model Cancer Epidemiology, March 31, 2012

44 Loco-recurrence after resection for ductal adenocarcinoma of the pancreas: predictors and implications for adjuvant chemoradiotherapy Journal of Cancer Research & Clinical Oncology, March 31, 2012

45 Ack1 Tyrosine Kinase Activation Correlates with Pancreatic Cancer Progression The American Journal of Pathology, March 31, 2012

46 Phase I Study of Rigosertib, an Inhibitor of the Phosphatidylinositol 3-Kinase and Polo-like Kinase 1 Pathways, Combined with Gemcitabine in Patients with Solid Tumors and Pancreatic Cancer Clinical Cancer Research, March 31, 2012    Clinical Article

47 Expression of claudins 7 and 18 in pancreatic ductal adenocarcinoma: association with features of differentiation Journal of Clinical Pathology, March 31, 2012

48 Postoperative Prognostic Predictors of Pancreatic Ductal Adenocarcinoma: Clinical Analysis and Immunoprofile on Tissue Microarrays Annals of Surgical Oncology, March 31, 2012

49 Insulin-like growth factor axis gene polymorphisms modify risk of pancreatic cancer Cancer Epidemiology, March 31, 2012

50 Circulating CD4+CD25+ Regulatory T Cells in Patients With Pancreatic Cancer Pancreas, March 31, 2012

51 Costs and trends in pancreatic cancer treatment Cancer, March 31, 2012

52 Clinical phase I/II trial to investigate neoadjuvant intensity-modulated short term radiation therapy and intraoperative radiation therapy in patients with primarily resectable pancreatic cancer Full Text BMC Cancer, March 31, 2012

53 Is there a role for the quantification of RRM1 and ERCC1 expression in pancreatic ductal adenocarcinoma Full Text BMC Cancer, March 31, 2012

54 Differentiation of autoimmune pancreatitis with pancreatic carcinoma remains a challenge to physicians Journal of Digestive Diseases, March 31, 2012

55 Hepatitis B Virus Status and Risk of Pancreatic Ductal Adenocarcinoma: A Case-Control Study From China Pancreas, March 31, 2012

56 Phase II Study of Panobinostat and Bortezomib in Patients with Pancreatic Cancer Progressing on Gemcitabine-based Therapy Anticancer Research, March 15, 2012    Clinical Article

57 Sequential FOLFOX-6 and gemcitabine for locally advanced and/or metastatic pancreatic cancer Medical Oncology, March 15, 2012    Clinical Article

58 A phase I/II, non-randomized, feasibility/safety and efficacy study of the combination of everolimus, cetuximab and capecitabine in patients with advanced pancreatic cancer Full Text Investigational New Drugs, March 15, 2012    Clinical Article

59 Contribution of CXCR4 and SMAD4 in predicting disease progression pattern and benefit from adjuvant chemotherapy in resected pancreatic adenocarcinoma Annals of Oncology, March 15, 2012

60 Metformin Inhibits Cell Proliferation, Migration and Invasion by Attenuating CSC Function Mediated by Deregulating miRNAs in Pancreatic Cancer Cells Cancer Prevention Research, March 15, 2012    Clinical Article

61 Multicentre phase II trial of trastuzumab and capecitabine in patients with HER2 overexpressing metastatic pancreatic cancer British Journal of Cancer, March 15, 2012    Clinical Article

62 Transforming Growth Factor Beta Receptor I Inhibitor Sensitizes Drug-resistant Pancreatic Cancer Cells to Gemcitabine Anticancer Research, March 15, 2012    Clinical Article

63 Advances in the treatment of pancreatic neuroendocrine tumours QJM: An International Journal of Medicine, March 15, 2012

64 Neoadjuvant Therapy of Pancreatic Cancer Full Text The Oncologist, March 15, 2012

65 The functional cytotoxic T lymphocyte-associated Protein 4 49G-to-A genetic variant and risk of pancreatic cancer Cancer, March 15, 2012

66 PDGFRβ expression in tumor stroma of pancreatic adenocarcinoma as a reliable prognostic marker Medical Oncology, March 15, 2012

Stereotactic ablative radiotherapy for stage I NSCLC: Recent advances and controversies Journal of Thoracic Disease, 08/05/2011

1 Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP Protocol B-24 Journal of Clinical Oncology, April 9, 2012

2 The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal Journal of Gastrointestinal Oncology, April 16, 2012    Free full text

3 Preoperative chemotherapy plus trastuzumab, lapatinib, or both in human epidermal growth factor receptor 2-positive operable breast cancer: Results of the randomized phase III CHER-LB study Journal of Clinical Oncology, April 12, 2012

4 Ovarian function suppression and fulvestrant as endocrine therapy in premenopausal women with metastatic breast cancer European Journal of Cancer, April 2, 2012

5 Metformin use is associated with better survival of diabetic patients with pancreatic cancer Clinical Cancer Research, April 4, 2012

6 Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study The Lancet, April 24, 2012

7 Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials The Lancet Oncology - Online First, March 22, 2012

8 Carboplatin- or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: the COCIS meta-analysis of individual patient data Journal of Clinical Oncology, April 5, 2012

9 Rapid-onset hypogonadism secondary to crizotinib use in men with metastatic nonsmall cell lung cancer Cancer, April 6, 2012

10 Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial The Lancet Oncology - Online First, March 28, 2012

11 Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial The Lancet - Early Online Publication, April 5, 2012

12 The effects of metformin on the survival of colorectal cancer patients with diabetes mellitus International Journal of Cancer, April 26, 2012

13 Infectious complications of chemotherapy in clinically aggressive mature B and T cell lymphomas European Journal of Internal Medicine , April 3, 2012

14 Carboplatin and paclitaxel with vs without bevacizumab in older patients with advanced non-small cell lung cancer JAMA, April 19, 2012

15 Association between tamoxifen treatment and diabetes Cancer, April 16, 2012

16 The utility of serum CA-125 in predicting extra-uterine disease in apparent early-stage endometrial cancer International Journal of Cancer, April 23, 2012

17 Pneumonitis associated with mTOR inhibitors therapy in patients with metastatic renal cell carcinoma: Incidence, radiographic findings and correlation with clinical outcome European Journal of Cancer, April 11, 2012

18 Digoxin use and the risk of cancers of the corpus uteri, ovary and cervix International Journal of Cancer, April 18, 2012

19 Gefitinib versus placebo as maintenance therapy in patients with locally advanced or metastatic non-small-cell lung cancer (INFORM; C-TONG 0804): a multicentre, double-blind randomised phase 3 trial The Lancet Oncology - Online First, April 20, 2012

20 Multicenter randomized phase II clinical trial comparing neoadjuvant oxaliplatin, capecitabine, and preoperative radiotherapy with or without cetuximab followed by total mesorectal excision in patients with high-risk rectal cancer (EXPERT-C) Journal of Clinical Oncology, April 9, 2012